Verified Nov 2026
Other
·

Mumbai, Maharashtra
·
Since 1968
Lupin Pharmaceuticals is a global pharmaceutical manufacturer headquartered in Mumbai, India, founded in 1968. The company operates across 10,000–50,000 employees with estimated revenue in the $1–5 billion band. Lupin ranks among the world's top 10 generic drug manufacturers, producing generics, specialty medicines, biosimilars, and over-the-counter products across cardiovascular, diabetes, respiratory, oncology, and women's health. Its manufacturing footprint spans India, the United States, Mexico, and Brazil, serving healthcare providers and consumers in over 100 markets.
Lupin Pharmaceuticals at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
1968
Headquarters
Mumbai, Maharashtra
Certifications
ISO 14001 · ISO 45001 · ISO 9001
Import activity
972
Industries
Automotive
Electric Vehicles
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
972
Named foreign suppliers
7
Top origins
India · Oman · Pakistan · France

Shared foreign counterparties do not establish that these companies buy from Lupin Pharmaceuticals.
What this tells a buyer
Lupin's customs data shows 972 recorded shipments, with primary origins in India, Oman, Pakistan, France, China, and the United Kingdom, alongside packaging suppliers from France and the United Kingdom.
The company holds ISO 9001, ISO 14001, and ISO 45001 certifications and manufactures complex generics, biosimilars, and active pharmaceutical ingredients.
Recent developments include the November 2026 European launch of biosimilar ranibizumab, March 2026 expansion of manufacturing capacity at Dabhasa in India, and a November 2025 oncology manufacturing block unveiled at Vizag.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
58 years in operation (founded 1968).
972 US import shipments on record.
Holds ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Overview
Lupin Pharmaceuticals is a global pharmaceutical manufacturer headquartered in Mumbai, India, founded in 1968. The company operates across 10,000–50,000 employees with estimated revenue in the $1–5 billion band. Lupin ranks among the world's top 10 generic drug manufacturers, producing generics, specialty medicines, biosimilars, and over-the-counter products across cardiovascular, diabetes, respiratory, oncology, and women's health. Its manufacturing footprint spans India, the United States, Mexico, and Brazil, serving healthcare providers and consumers in over 100 markets.
At a glance
Attribute | Detail |
|---|---|
Founded | 1968 |
Headquarters | Mumbai, Maharashtra |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
Certifications | ISO 14001 · ISO 45001 · ISO 9001 |
What Lupin Pharmaceuticals makes
The company holds ISO 9001, ISO 14001, and ISO 45001 certifications and manufactures complex generics, biosimilars, and active pharmaceutical ingredients.
Products and capabilities described on the company's own site include LED (source: lupin.com).
Certifications
Lupin Pharmaceuticals is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — lupin.com
ISO 45001 — lupin.com
ISO 9001 — sourceready.com
Trade and customs footprint
Lupin's customs data shows 972 recorded shipments, with primary origins in India, Oman, Pakistan, France, China, and the United Kingdom, alongside packaging suppliers from France and the United Kingdom. US customs bill-of-lading records list 972 inbound shipments across 7 foreign suppliers, with top origins including India · Oman · Pakistan · France.
Latest developments
2026-11-12 — Lupin Announces European Launch of Biosimilar Ranibizumab - Lupin | Press Release (lupin.com)
2026-03-19 — Lupin Manufacturing Solutions Announces Expansion of Manufacturing Facility at Dabhasa, India - Lupin | Press Release (lupin.com)
2026-02-02 — Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases - Lupin | Press Release (lupin.com)
2025-12-04 — Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ (Pegfilgrastim-unne) in the United States - Lupin | Press Release (lupin.com)
2025-11-12 — Lupin Manufacturing Solutions Unveils Dedicated Oncology Block at Vizag, India - Lupin | Press Release (lupin.com)
2025-10-28 — Governor Murphy and Local Leaders Attend Ribbon-Cutting Ceremony, Marking the Inauguration of Lupin’s New Corporate Offices in Bridgewater - Lupin | Press Release (lupin.com)
Facilities
Lupin Pharmaceuticals is headquartered in Mumbai, Maharashtra. Public sources also reference these locations:
India — lupin.com
Company details
Recent developments include the November 2026 European launch of biosimilar ranibizumab, March 2026 expansion of manufacturing capacity at Dabhasa in India, and a November 2025 oncology manufacturing block unveiled at Vizag. Lupin Pharmaceuticals was founded in 1968, has an estimated 10,000-50,000 employees, and is headquartered in Mumbai, Maharashtra. On the LightSource stability read it is rated "Established & active": 58 years in operation (founded 1968). 972 US import shipments on record. Holds ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Lupin Pharmaceuticals do?
Lupin Pharmaceuticals is a global pharmaceutical manufacturer headquartered in Mumbai, India, founded in 1968. The company operates across 10,000–50,000 employees with estimated revenue in the $1–5 billion band. Lupin ranks among the world's top 10 generic drug manufacturers, producing generics, specialty medicines, biosimilars, and over-the-counter products across cardiovascular, diabetes, respiratory, oncology, and women's health. Its manufacturing footprint spans India, the United States, Mexico, and Brazil, serving healthcare providers and consumers in over 100 markets.
Where is Lupin Pharmaceuticals headquartered?
Lupin Pharmaceuticals is headquartered in Mumbai, Maharashtra (Pipe Line Road, Mumbai, Maharashtra, 400070).
When was Lupin Pharmaceuticals founded?
Lupin Pharmaceuticals was founded in 1968.
How big is Lupin Pharmaceuticals?
Lupin Pharmaceuticals has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Lupin Pharmaceuticals hold?
Lupin Pharmaceuticals lists ISO 14001 · ISO 45001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Lupin Pharmaceuticals import from overseas suppliers?
US customs bill-of-lading records show 972 inbound shipments for Lupin Pharmaceuticals, with top origins including India · Oman · Pakistan · France.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Phone
'+91 22 6640 2323
Certification
ISO 14001 · ISO 45001 · ISO 9001
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
